ACM
MDT icon

Asymmetry Capital Management’s Medtronic MDT Stock Holding History

Asymmetry Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83,737
Closed -$10.5M – 33
2021
Q3 		$10.5M Buy
+83,737
New +$10.8M 6.31% 2
2017
Q4 		– Sell
-16,295
Closed -$1.27M – 35
2017
Q3 		$1.27M Sell
16,295
-48,741
-75% -$4.05M 1.47% 22
2017
Q2 		$5.77M Buy
+65,036
New +$5.48M 6.84% 2

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Asymmetry Capital Management's MDT Position: Q4 2021 in Review

Asymmetry Capital Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 83,737 shares — an estimated $10.5M sold.

Asymmetry Capital Management first reported a position in MDT in Q2 2017 and held it in 3 quarters. The position peaked at $10.5M in Q3 2021. 2,058 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Asymmetry Capital Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 83,737 Medtronic shares in Q4 2021, an estimated $10.5M.
  • Asymmetry Capital Management first reported a position in Medtronic in Q2 2017 and held it in 3 quarters.
  • Asymmetry Capital Management's Medtronic position peaked at $10.5M in Q3 2021.
  • 2,058 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.